Literature DB >> 24343348

E-cigarettes and cardiovascular risk: beyond science and mysticism.

Giuseppe Lippi1, Emmanuel J Favaloro2, Tiziana Meschi3, Camilla Mattiuzzi4, Loris Borghi3, Gianfranco Cervellin5.   

Abstract

Cigarette smoking is the most important cause of premature death, and it is currently listed as a major independent risk factor for cardiovascular disease. Because of restrictive measures and widespread control policies, tobacco companies are now using aggressive marketing strategies in favor of smokeless tobacco, including electronic nicotine delivery systems, which are also known as electronic cigarettes or e-cigarettes. Although the regular use of these devices appears less hazardous than traditional cigarettes or other forms of smokeless tobacco, recent studies have shown that various potentially harmful substances, especially nicotine, ultraparticles, and volatile organic compounds, may be effectively inhaled or liberated in exhaled air during repeated e-cigarette puffing. This would enhance the risk of cardiac arrhythmias and hypertension, which may predispose some users to increased risk of cardiovascular events, which may be further magnified by other potential adverse effects such as arrhythmias, increased respiratory, and flow respiratory resistance. Some cases of intoxication have also been described, wherein large amounts of nicotine and other harmful compounds may be effectively absorbed. As the use of e-cigarettes is continuously rising, and it is also considered a potentially effective method for smoking cessation, more focused research is urgently needed to definitely establish the cardiovascular safeness of these devices. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24343348     DOI: 10.1055/s-0033-1363468

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  20 in total

Review 1.  E-cigarette use as a potential cardiovascular disease risk behavior.

Authors:  Krysten W Bold; Suchitra Krishnan-Sarin; Catherine M Stoney
Journal:  Am Psychol       Date:  2018-11

2.  A public health strategy for e-cigarettes.

Authors:  Sven Schneider; Katharina Diehl
Journal:  Wien Klin Wochenschr       Date:  2015-05-27       Impact factor: 1.704

Review 3.  Measuring perceptions related to e-cigarettes: Important principles and next steps to enhance study validity.

Authors:  Laura A Gibson; MeLisa R Creamer; Alison B Breland; Aida Luz Giachello; Annette Kaufman; Grace Kong; Terry F Pechacek; Jessica K Pepper; Eric K Soule; Bonnie Halpern-Felsher
Journal:  Addict Behav       Date:  2017-11-20       Impact factor: 3.913

4.  Adolescents' attitudes towards e-cigarette ingredients, safety, addictive properties, social norms, and regulation.

Authors:  Anuradha Gorukanti; Kevin Delucchi; Pamela Ling; Raymond Fisher-Travis; Bonnie Halpern-Felsher
Journal:  Prev Med       Date:  2016-10-20       Impact factor: 4.018

5.  Adolescents' Perceptions of Risks and Benefits of Conventional Cigarettes, E-cigarettes, and Marijuana: A Qualitative Analysis.

Authors:  Maria L Roditis; Bonnie Halpern-Felsher
Journal:  J Adolesc Health       Date:  2015-06-23       Impact factor: 5.012

Review 6.  Overview of Electronic Nicotine Delivery Systems: A Systematic Review.

Authors:  Allison M Glasser; Lauren Collins; Jennifer L Pearson; Haneen Abudayyeh; Raymond S Niaura; David B Abrams; Andrea C Villanti
Journal:  Am J Prev Med       Date:  2016-11-30       Impact factor: 5.043

7.  Characterizing use patterns and perceptions of relative harm in dual users of electronic and tobacco cigarettes.

Authors:  Olga Rass; Lauren R Pacek; Patrick S Johnson; Matthew W Johnson
Journal:  Exp Clin Psychopharmacol       Date:  2015-09-21       Impact factor: 3.157

Review 8.  Cardiovascular toxicity of nicotine: Implications for electronic cigarette use.

Authors:  Neal L Benowitz; Andrea D Burbank
Journal:  Trends Cardiovasc Med       Date:  2016-03-10       Impact factor: 6.677

9.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  J Am Coll Cardiol       Date:  2019-03-17       Impact factor: 24.094

Review 10.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  Circulation       Date:  2019-03-17       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.